Metro Healthcare Indonesia (CARE) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.11x

Metro Healthcare Indonesia (CARE) has a Cash Flow Reinvestment Rate of 0.11x as of September 2025, reinvesting Rp1.77 Billion (capex Rp1.77 Billion ) from operating cash flow of Rp16.50 Billion. See CARE cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.11x

(Capex + Investments) / Operating CF

Total Reinvested

Rp1.77 Billion

Capex + Investments

Operating Cash Flow

Rp16.50 Billion

IDR

Capital Expenditures

Rp1.77 Billion

IDR

Metro Healthcare Indonesia Cash Flow Reinvestment Rate (2020–2021)

Historical reinvestment intensity for Metro Healthcare Indonesia across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Metro Healthcare Indonesia.

Annual Cash Flow Reinvestment Rate for Metro Healthcare Indonesia (2020–2021)

Year-by-year capital reinvestment analysis for Metro Healthcare Indonesia. See CARE free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (IDR)	Operating CF	Capex	YoY Change
2021	16.13x	Rp760.40 Billion	Rp47.13 Billion	Rp310.40 Billion	▲ +49.7%
2020	10.78x	Rp542.27 Billion	Rp50.30 Billion	Rp522.27 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow